EUVIMEDOpdag EUVIMED
Crossref

Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed‐batch production performance in CHO recombinant clones

Luke Nelson, Mike Veling, Fatemeh Farhangdoust, Xuezhu Cai, Steve Huhn iD, Veronica Soloveva, Meiping Chang iD

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28518 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2023. Written by Luke Nelson and 6 co-authors. Institution: Merck & Co., Inc., Rahway, New Jersey, USA. Major MEDLINE topics: Epigenesis, Genetic, Transcriptome. Cited 6 times so far (Crossref); 39 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Stable, highly productive mammalian cells are critical for manufacturing affordable and effective biological medicines. Establishing a rational design of optimal biotherapeutic expression systems requires understanding how cells support the high demand for efficient biologics production. To that end, we performed transcriptomics and high‐throughput imaging studies to identify putative genes and morphological features that underpin differences in antibody productivity among clones from a Chinese hamster ovary cell line. During log phase growth, we found that the expression of genes involved in biological processes related to cellular morphology varied significantly between clones with high specific productivity (qP > 35 pg/cell/day) and low specific productivity (qP < 20 pg/cell/day). At Day 10 of a fed‐batch production run, near peak viable cell density, differences in gene expression related to metabolism, epigenetic regulation, and proliferation became prominent. Furthermore, we identified a subset of genes whose expression predicted overall productivity, including glutathione synthetase (Gss) and lactate dehydrogenase A (LDHA). Finally, we demonstrated the feasibility of cell painting coupled with high‐throughput imaging to assess the morphological properties of intracellular organelles in relation to growth and productivity in fed‐batch production. Our efforts lay the groundwork for systematic elucidation of clone performance using a multiomics approach that can guide future process design strategies.

Subjects

MeSH terms (MEDLINE)

Epigenesis, GeneticTranscriptomeCricetinaeAnimalsCricetulusCHO CellsClone CellsRecombinant ProteinsBatch Cell Culture Techniques

Author keywords

CHObiologicscell line developmentcell paintingmorphological profilingtranscriptomics

Substances

Recombinant Proteins

Authors and institutions

  • Merck & Co., Inc., Rahway, New Jersey, USA.

ORCID profiles: Steve Huhn, Meiping Chang

Cite

APA

Nelson, L., Veling, M., Farhangdoust, F., Cai, X., Huhn, S., Soloveva, V., & Chang, M. (2023). Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed‐batch production performance in CHO recombinant clones. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28518

Vancouver

Nelson L, Veling M, Farhangdoust F, Cai X, Huhn S, Soloveva V, et al. Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed‐batch production performance in CHO recombinant clones. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28518

BibTeX
@article{Nelson2023,
  author = {Nelson, Luke and Veling, Mike and Farhangdoust, Fatemeh and Cai, Xuezhu and Huhn, Steve and Soloveva, Veronica and Chang, Meiping},
  title = {Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed‐batch production performance in CHO recombinant clones},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28518}
}
Start for free →